{"id":2013,"date":"2022-01-17T14:48:04","date_gmt":"2022-01-17T13:48:04","guid":{"rendered":"http:\/\/invivo.partners\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/"},"modified":"2025-10-28T18:37:27","modified_gmt":"2025-10-28T17:37:27","slug":"difficult-indications-pancreatic-cancer","status":"publish","type":"post","link":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","title":{"rendered":"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES"},"content":{"rendered":"

Com m\u00e9s gran \u00e9s la necessitat cl\u00ednica i la prevalen\u00e7a, m\u00e9s gran \u00e9s l\u2019esfor\u00e7 dels cient\u00edfics d\u2019arreu del m\u00f3n per intentar resoldre un problema.
\nL\u2019adenocarcinoma ductal de p\u00e0ncrees (PDAC) continua sent avui una de les necessitats cl\u00edniques no resoltes m\u00e9s importants. \u00c9s una malaltia devastadora amb un pron\u00f2stic desfavorable i es preveu que es converteixi en el segon c\u00e0ncer m\u00e9s mortal l\u2019any 2030.
\nActualment, la taxa global de superviv\u00e8ncia als 5 anys \u00e9s inferior al 10%, malgrat tots els esfor\u00e7os realitzats.<\/p>\n

Tanmateix, cada mes s\u2019estan impulsant noves ter\u00e0pies, i el ritme d\u2019innovaci\u00f3 en aquest camp \u00e9s extraordinari.<\/p>\n

Totes les grans necessitats cl\u00edniques no resoltes poden representar una bona oportunitat d\u2019inversi\u00f3.
\nAqu\u00ed tens un mapa conceptual (no exhaustiu) amb algunes de les alternatives i dianes m\u00e9s innovadores que s\u2019estan desenvolupant.
\nUn mapa per orientar-se en el panorama i evitar perdre\u2019s entre les diferents categories i enfocaments.<\/p>\n

Pots trobar totes les meves quick notes a #quick_notes_LP<\/strong><\/a><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Com m\u00e9s gran \u00e9s la necessitat cl\u00ednica i la prevalen\u00e7a, m\u00e9s gran \u00e9s l\u2019esfor\u00e7 dels cient\u00edfics d\u2019arreu del m\u00f3n per intentar resoldre un problema. L\u2019adenocarcinoma ductal de p\u00e0ncrees (PDAC) continua sent avui una de les necessitats cl\u00edniques no resoltes m\u00e9s importants. \u00c9s una malaltia devastadora amb un pron\u00f2stic desfavorable i es preveu que es converteixi<\/p>\n","protected":false},"author":1,"featured_media":2010,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[585],"tags":[],"class_list":["post-2013","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ideas-lab-2"],"acf":[],"yoast_head":"\nINDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES - Invivo Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES - Invivo Partners\" \/>\n<meta property=\"og:description\" content=\"Com m\u00e9s gran \u00e9s la necessitat cl\u00ednica i la prevalen\u00e7a, m\u00e9s gran \u00e9s l\u2019esfor\u00e7 dels cient\u00edfics d\u2019arreu del m\u00f3n per intentar resoldre un problema. L\u2019adenocarcinoma ductal de p\u00e0ncrees (PDAC) continua sent avui una de les necessitats cl\u00edniques no resoltes m\u00e9s importants. \u00c9s una malaltia devastadora amb un pron\u00f2stic desfavorable i es preveu que es converteixi\" \/>\n<meta property=\"og:url\" content=\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Invivo Partners\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-17T13:48:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T17:37:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/invivo.partners\/wp-content\/uploads\/2022\/01\/DIFFICULT-INDICATIONS-PANCREATIC-CANCER.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"999\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"invivo\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"invivo\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\"},\"author\":{\"name\":\"invivo\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\"},\"headline\":\"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES\",\"datePublished\":\"2022-01-17T13:48:04+00:00\",\"dateModified\":\"2025-10-28T17:37:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\"},\"wordCount\":187,\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"articleSection\":[\"Ideas Lab\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\",\"url\":\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\",\"name\":\"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES - Invivo Partners\",\"isPartOf\":{\"@id\":\"https:\/\/invivo.partners\/#website\"},\"datePublished\":\"2022-01-17T13:48:04+00:00\",\"dateModified\":\"2025-10-28T17:37:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/invivo.partners\/ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/invivo.partners\/#website\",\"url\":\"https:\/\/invivo.partners\/\",\"name\":\"Invivo Capital\",\"description\":\"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.\",\"publisher\":{\"@id\":\"https:\/\/invivo.partners\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/invivo.partners\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/invivo.partners\/#organization\",\"name\":\"Invivo Capital\",\"url\":\"https:\/\/invivo.partners\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"contentUrl\":\"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg\",\"width\":1200,\"height\":630,\"caption\":\"Invivo Capital\"},\"image\":{\"@id\":\"https:\/\/invivo.partners\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789\",\"name\":\"invivo\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/invivo.partners\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g\",\"caption\":\"invivo\"},\"url\":\"https:\/\/invivo.partners\/ca\/author\/invivocapital\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES - Invivo Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","og_locale":"ca_ES","og_type":"article","og_title":"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES - Invivo Partners","og_description":"Com m\u00e9s gran \u00e9s la necessitat cl\u00ednica i la prevalen\u00e7a, m\u00e9s gran \u00e9s l\u2019esfor\u00e7 dels cient\u00edfics d\u2019arreu del m\u00f3n per intentar resoldre un problema. L\u2019adenocarcinoma ductal de p\u00e0ncrees (PDAC) continua sent avui una de les necessitats cl\u00edniques no resoltes m\u00e9s importants. \u00c9s una malaltia devastadora amb un pron\u00f2stic desfavorable i es preveu que es converteixi","og_url":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","og_site_name":"Invivo Partners","article_published_time":"2022-01-17T13:48:04+00:00","article_modified_time":"2025-10-28T17:37:27+00:00","og_image":[{"width":800,"height":999,"url":"https:\/\/invivo.partners\/wp-content\/uploads\/2022\/01\/DIFFICULT-INDICATIONS-PANCREATIC-CANCER.jpg","type":"image\/jpeg"}],"author":"invivo","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"invivo","Temps estimat de lectura":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#article","isPartOf":{"@id":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/"},"author":{"name":"invivo","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789"},"headline":"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES","datePublished":"2022-01-17T13:48:04+00:00","dateModified":"2025-10-28T17:37:27+00:00","mainEntityOfPage":{"@id":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/"},"wordCount":187,"publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"articleSection":["Ideas Lab"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","url":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/","name":"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES - Invivo Partners","isPartOf":{"@id":"https:\/\/invivo.partners\/#website"},"datePublished":"2022-01-17T13:48:04+00:00","dateModified":"2025-10-28T17:37:27+00:00","breadcrumb":{"@id":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/invivo.partners\/ca\/2022\/01\/17\/difficult-indications-pancreatic-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/invivo.partners\/ca\/"},{"@type":"ListItem","position":2,"name":"INDICACIONS DIF\u00cdCILS: C\u00c0NCER DE P\u00c0NCREES"}]},{"@type":"WebSite","@id":"https:\/\/invivo.partners\/#website","url":"https:\/\/invivo.partners\/","name":"Invivo Capital","description":"Somos un fondo de capital riesgo especializado en proyectos early-stage del sector salud.","publisher":{"@id":"https:\/\/invivo.partners\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/invivo.partners\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/invivo.partners\/#organization","name":"Invivo Capital","url":"https:\/\/invivo.partners\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/","url":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","contentUrl":"http:\/\/invivo.partners\/wp-content\/uploads\/2020\/04\/InvivoCapital_Banner.jpg","width":1200,"height":630,"caption":"Invivo Capital"},"image":{"@id":"https:\/\/invivo.partners\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/invivo.partners\/#\/schema\/person\/f382d91fa1fbbe4bb94f3093438e5789","name":"invivo","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/invivo.partners\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3c1e935daee28cd9cccdda9f9bb7f784c23881fa1325206e7c53c9119500139c?s=96&d=mm&r=g","caption":"invivo"},"url":"https:\/\/invivo.partners\/ca\/author\/invivocapital\/"}]}},"_links":{"self":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/2013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/comments?post=2013"}],"version-history":[{"count":2,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/2013\/revisions"}],"predecessor-version":[{"id":3941,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/posts\/2013\/revisions\/3941"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media\/2010"}],"wp:attachment":[{"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/media?parent=2013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/categories?post=2013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/invivo.partners\/ca\/wp-json\/wp\/v2\/tags?post=2013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}